创东方投资高宇辉：马年的投资机遇将孕育在四个“确定性”之中

Core Insights - The company expresses optimism about China's economic resilience and strategic direction despite external challenges and domestic transformation pressures [1] - The investment strategy focuses on sectors such as advanced manufacturing, artificial intelligence, biomedicine, new energy, and new materials, aiming for deep engagement and value creation [1] - The company has achieved significant milestones, managing nearly 30 billion RMB and investing in over 350 companies, with more than 40 successfully exiting through IPOs [1] Group 1: Market Environment - The macroeconomic narrative is complex, but three constants guide the company's judgment: the direction of technological revolutions, the urgent need for industrial upgrades in China, and the survival of the fittest in the venture capital ecosystem [2] - The technological revolution is characterized by advancements in AI, life sciences, energy technology, and low-altitude economy, which are accelerating towards industrialization [2] - The shift from supply chain security to excellence and from cost advantages to technological advantages is essential for survival and competition, creating historic demand for startups addressing core industrial bottlenecks [2] Group 2: Investment Outlook - The investment landscape is focused on four areas of certainty: the positive outlook for capital markets, the clarity of the industrial revolution led by AI and new energy, the commitment to technological independence, and the growing importance of health and wellness sectors [3][4] - China's stable economic growth positions it as a cornerstone of global economic development, enhancing the prospects for its capital markets [3] - The emphasis on domestic innovation in sectors like semiconductors, high-end equipment, and biotechnology is now a national strategy, creating a golden opportunity for companies with core technological capabilities [3] Group 3: Health Sector Investment - The changing population structure and rising health awareness are driving investment logic in the pharmaceutical and healthcare sectors beyond cyclical fluctuations [4] - Areas such as innovative drugs, high-end medical devices, and broader health management are seen as long-term investment tracks that combine technological attributes with social value [4] Group 4: Future Commitment - The company reaffirms its commitment to investing in early-stage, small-scale, and hard technology ventures, leveraging its deep research and industry ecosystem resources to identify resilient investment targets [5] - The outlook for the future is hopeful, with a call for collaboration to navigate the opportunities presented in the coming year [5]